1. Stop the chemo now and then go back on it when the cancer grows back, which it will. This would most likely be a matter of months. Merede rejected this alternative.
2. Do surgery now (which he recommends) and then most likely finishing out the scheduled 13 chemo treatments after surgery. Why this recommendation? Because chemo/Avistin can only stop the cancer's progress and shrink the tumors back but by itself this treatment is just a tool, it is not an end. Surgery, under the condition wherein Merede has (at least) two tumors possibly could bring the cancer to an end although it is unlikely. But it would definitely clean up some of the cancer spots. So she would end up her medical treatments in better shape than without surgery for sure along with having a small chance of being rid of it.
So this is a very good development, one that Dr. Brett was hoping for at the onset of her treatments. The really good news, given the reality of what Merede is facing now, came next.
Dr. Brett said that liver surgery is way too complex, difficult and delicate to be done locally, meaning the Santa Rosa area. Therefore he recommended that Merede go to Dr. Robert Warren at UCSF. Warren basically does liver cancer surgery most all day, every day. Dr. Warren does conventional surgery and also uses two methods of minimally invasive surgery, RFA (radiofrequency ablation) and HIFUS, which is high intensity focused ultra sound. (You will remember that I have written about the RFA procedure before as Dr. Michael Broffman suggested we look at it and at HIFUS if surgery was indicated.) Sometimes Dr. Warren uses two of these procedures at once. The RFA and HIFUS procedures are very cutting-edge.
Since I had already talked 10 days ago with Dr. Warren's reference research office, which sent me medical journal articles on RFA, and discussed Merede's condition with his scheduling nurse who confirmed that they will accept Merede's health insurance payments and had then discussed this option with Merede beforehand, it didn't take but a minute for Merede to say that is what she wanted to do.
During chemo Dr. Brett's office called that of Dr. Warren and made arrangements to rush all of Merede's medical records down there. They will be evaluated ... hopefully this week ... and then UCSF will contact Merede about her coming in ... hopefully next week ... for a Tri-Level, 3D, PET-CT scan which will give Dr. Warren what he needs to know to determine what kind of surgical procedure he will want to use.
The surgery cannot occur until 6 weeks since the last Avistin (and 3 - 4 weeks after the last chemo) treatment so the surgery most likely will occur sometime in July. Therefore Merede will have a break from her bi-weekly infusions during the staying out period plus some amount of time off during the surgery period. The surgery period (defined as the procedure plus recovery) will be a month if she has conventional surgery or if she has a combination of conventional and minimally invasive procedure. If she just has a minimally invasive procedure the surgery period will be much shorter.
Dr. Brett stated that this upcoming liver surgery is much more serious that her prior colon surgery. This is, he said, another reason to get her into a major hospital such as UCSF. UCSF is ranked #8 out of the top 50 cancer treatment hospitals in the US.
Here is some info on Dr. Warren.
"Dr. Robert Warren is Chief of the Surgical Oncology Program and Professor of Surgery at UCSF where he also specializes in gastrointestinal and liver cancer.
Dr. Warren earned a medical degree at the University of Minnesota, where he also completed a general surgery residency. After completing an oncology research fellowship at Memorial Sloan-Kettering Cancer Center in New York, he was an associate physician at Rockefeller University in New York. A board-certified surgeon, he joined UCSF Medical Center in 1988.
Dr. Warren is involved in clinical and laboratory research which has centered on the biology of colorectal cancer metastasis that includes Vascular Endothelial Growth Factor (VEGF), Insulin-Like Growth Factors and Their Binding Proteins AS Modulators of Growth of Colorectal Cancer Metastases and Cytogenetics of Colorectal Cancer Metastasis. The laboratory work focuses on two areas: 1) autocrine growth factors and angiogenesis in colorectal cancer 2) molecular features which predict clinical outcome in primary and metastatic colorectal cancer."
To sum up, Dr. Brett has done a great job of selecting the chemo/Avistin materials and then applying them in amounts that have been extremely effective. (He modestly said "Yes, it's pretty much a miracle." Now we have a top surgeon at a top ranked hospital. And then we have the renowned Dr. Broffman, to guide the post medical treatment phase of keeping the cancer in remission.
Go Team! Go Merede!!!!
Bob
No comments:
Post a Comment